The potential to use metformin to treat Alzheimers is also provided by data indicating that metformin targets monoacylglycerol lipase, an enzyme responsible for generating pro-inflammatory eicosanoids from 2-arachidonoyl glycerol (258)
25,26 GIP is known to bind to the GLP-1R/GIPR heterodimer, a member of the family of G protein-coupled receptors
You can read the full article at LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism
At the time, weight loss medications were not as effective as they are today, and obesity was not yet widely treated as a chronic medical condition
Gut health beyond probiotics: the bigger picture Probiotics are one tool in a larger toolkit
Samms RJ, Coghlan MP, Sloop KW (2020) How may GIP enhance the therapeutic efficacy of GLP-1